Clarithromycin As an Alternative and Prophylactic Agent in a Hematopoietic Stem Cell Transplantation Patient

Katsushi Tajima; Shuhei Okuyama; Taichi Terada; Daisuke Akaneya; Ryuichiro Hori; Shuichi Abe; Tsuguo Honma; Riko Tsumanuma; Eijiro Omoto; Junko Ito; Tohru Gonoi

doi:10.12659/AJCR.931731

15 June 2021 : Case report Japan

Clarithromycin As an Alternative and Prophylactic Agent in a Hematopoietic Stem Cell Transplantation Patient

Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Unexpected drug reaction, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)

Katsushi Tajima^1ABCDEFG*, Shuhei Okuyama^1B, Taichi Terada^1B, Daisuke Akaneya^2BC, Ryuichiro Hori^3D, Shuichi Abe^4B, Tsuguo Honma^5D, Riko Tsumanuma^1B, Eijiro Omoto^1B, Junko Ito^6CD, Tohru Gonoi^6CD

DOI: 10.12659/AJCR.931731

Am J Case Rep 2021; 22:e931731

Authors information Article notes Copyright and License information

Clarithromycin As an Alternative and Prophylactic Agent in a Hematopoietic Stem Cell Transplantation Patient

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy